Vera J Suman Selected Research

Paraffin

12/2014	Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
11/2011	SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.
12/2005	Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vera J Suman Research Topics

Disease

74	Breast Neoplasms (Breast Cancer) 05/2024 - 05/2002
69	Neoplasms (Cancer) 03/2024 - 06/2002
20	Melanoma (Melanoma, Malignant) 02/2024 - 06/2002
9	Disease Progression 01/2019 - 09/2003
8	Triple Negative Breast Neoplasms 01/2024 - 10/2014
7	Multiple Myeloma 01/2022 - 07/2018
5	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 10/2010
5	Neoplasm Metastasis (Metastasis) 10/2018 - 06/2002
4	Pathologic Complete Response 01/2024 - 01/2017
3	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 12/2003
3	Fatigue 08/2017 - 10/2010
3	Hypertension (High Blood Pressure) 08/2017 - 09/2012
3	Anaplastic Thyroid Carcinoma 01/2013 - 10/2010
2	Residual Neoplasm 01/2024 - 10/2020
2	Neutropenia 01/2023 - 12/2005
2	Warts (Wart) 02/2005 - 12/2003
2	Carcinoma (Carcinomatosis) 08/2002 - 05/2002
1	Anemia 01/2023

Drug/Important Bio-Agent (IBA)

19	Estrogen ReceptorsIBA 01/2024 - 03/2006
17	Tamoxifen FDA LinkGeneric 01/2020 - 09/2003
14	Aromatase InhibitorsIBA 04/2023 - 09/2003
12	Trastuzumab (Herceptin)FDA Link 01/2021 - 06/2002
11	Anastrozole (Arimidex)FDA LinkGeneric 05/2024 - 09/2003
11	Paclitaxel (Taxol)FDA LinkGeneric 11/2014 - 10/2005
10	Letrozole (Femara)FDA LinkGeneric 04/2023 - 09/2003
8	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2007
8	exemestane (Aromasin)FDA Link 04/2023 - 09/2003
8	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2017 - 12/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2009
7	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2014 - 04/2002
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2014 - 09/2004
6	Phenobarbital (Luminal)FDA Link 01/2024 - 06/2011
6	pazopanib FDA Link 01/2020 - 10/2010
6	ErbB Receptors (EGF Receptor)IBA 11/2014 - 09/2004
6	Carboplatin (JM8)FDA LinkGeneric 02/2013 - 01/2005
5	Estrogens (Estrogen)FDA Link 05/2024 - 04/2005
5	4-hydroxy-N-desmethyltamoxifenIBA 01/2020 - 12/2005
4	Estradiol (Delestrogen)FDA LinkGeneric 05/2024 - 08/2009
4	130-nm albumin-bound paclitaxelIBA 03/2024 - 04/2011
4	Bevacizumab (Avastin)FDA Link 03/2024 - 01/2009
4	Fulvestrant (Faslodex)FDA Link 01/2024 - 03/2006
4	RNA (Ribonucleic Acid)IBA 01/2024 - 07/2004
4	Lenalidomide (CC 5013)FDA Link 01/2022 - 07/2018
4	Aromatase (CYP19)IBA 01/2020 - 01/2010
4	Hormones (Hormone)IBA 12/2017 - 10/2009
4	VaccinesIBA 01/2016 - 08/2006
3	Estrone FDA Link 05/2024 - 01/2010
3	Androgen Receptors (Androgen Receptor)IBA 06/2022 - 01/2017
3	taxaneIBA 01/2021 - 10/2012
3	human ERBB2 proteinIBA 01/2019 - 11/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2009
3	Phosphotransferases (Kinase)IBA 08/2017 - 10/2010
3	Peptides (Polypeptides)IBA 01/2016 - 08/2006
3	ParaffinIBA 12/2014 - 12/2005
3	B 31IBA 11/2014 - 10/2005
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2011 - 08/2006
3	EnzymesIBA 01/2010 - 01/2007
2	Estrogen Receptor betaIBA 02/2022 - 10/2018
2	Bortezomib (Velcade)FDA Link 12/2021 - 07/2010
2	Immunomodulating AgentsIBA 12/2021 - 07/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 01/2016
2	AnthracyclinesIBA 01/2021 - 12/2017
2	Everolimus FDA Link 01/2020 - 01/2018
2	IpilimumabIBA 01/2020 - 07/2018
2	Interleukin-2 (IL2)IBA 07/2018 - 10/2011
2	Cytostatic AgentsIBA 01/2018 - 12/2017
2	Estrogen Receptor alphaIBA 01/2018 - 11/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2017 - 03/2006
2	Proteins (Proteins, Gene)FDA Link 04/2017 - 06/2002
2	AntigensIBA 01/2016 - 12/2008
2	antineoplaston A10 (A 10)IBA 08/2015 - 08/2002
2	A-Form DNA (A-DNA)IBA 12/2014 - 01/2007
2	Temozolomide (Temodar)FDA LinkGeneric 02/2013 - 01/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013 - 09/2012
2	Protein Subunit VaccinesIBA 10/2011 - 08/2006
2	Monatide (IMS 3015)IBA 10/2011 - 08/2006
2	Tyrosine Kinase InhibitorsIBA 10/2010 - 04/2008
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 12/2008 - 08/2006
2	Interleukin-17 (Interleukin 17)IBA 09/2008 - 04/2006
2	KW 2189IBA 01/2007 - 06/2002
2	Megestrol Acetate (Borea)FDA LinkGeneric 05/2005 - 12/2002
2	SuspensionsIBA 12/2002 - 05/2002
1	PlatinumIBA 03/2024
1	Immunoconjugates (Immunoconjugate)IBA 03/2024
1	cobimetinibIBA 02/2024
1	VemurafenibIBA 02/2024
1	atezolizumabIBA 02/2024

Therapy/Procedure

50	Therapeutics 03/2024 - 06/2002
23	Drug Therapy (Chemotherapy) 01/2024 - 04/2002
15	Neoadjuvant Therapy 01/2024 - 01/2010
4	Immunotherapy 02/2024 - 07/2018
4	Lymph Node Excision (Lymph Node Dissection) 10/2020 - 10/2013
4	Adjuvant Chemotherapy 11/2014 - 10/2005
3	Radiotherapy 01/2024 - 02/2005
3	Aftercare (After-Treatment) 12/2017 - 03/2006
3	Drug Tapering 08/2017 - 10/2010
2	Stem Cell Transplantation 05/2021 - 01/2016
2	Brachytherapy 10/2020 - 08/2002
2	Salvage Therapy 01/2020 - 12/2003
2	Laparotomy 02/2005 - 12/2003